tldrdailynews.com logo

Breakthrough in Multiple Myeloma Treatment with Single-Dose CAR-T Therapy

1 min read
Source: Medical Xpress
Breakthrough in Multiple Myeloma Treatment with Single-Dose CAR-T Therapy
Photo: Medical Xpress
TL;DR

A study shows that a single infusion of CAR-T therapy cilta-cel can lead to at least five years of remission in about one-third of patients with relapsed or refractory multiple myeloma, suggesting potential curative outcomes for some patients.

Topics:businesshealth#cancer-treatment#car-t-therapy#cilta-cel#health#long-term-remission#multiple-myeloma
Share this article
  1. Single-dose CAR-T therapy potentially curative in multiple myeloma  Medical Xpress
  2. From No Hope to a Potential Cure for a Deadly Blood Cancer  The New York Times
  3. Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting  Yahoo Finance
  4. Israeli researchers help achieve breakthrough in myeloma treatment  Ynetnews
  5. Ciltacabtagene Autoleucel Delivers Lasting Remissions in Relapsed or Refractory Multiple Myeloma  The ASCO Post

Want the full story? Read the original reporting

Read on Medical Xpress